Terug
Dagbereik
€ 72,00
€ 79,01
52-Weeksbereik
€ 61,96
€ 138,70
Volume
224.285
50D / 200D Gem.
€ 82,07
/
€ 90,49
Vorige Slotkoers
€ 79,59
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 456,8 | 0,3 |
| P/B | 7,1 | 2,9 |
| ROE % | 2,3 | 3,7 |
| Net Margin % | 2,4 | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 130,33
+75.9%
Low: € 110,00
High: € 150,00
Forward K/W
169,9
Forward WPA
€ 0,47
WPA Groei (sch.)
+0,0%
Omzet Sch.
440 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,27
€ 1,23 – € 1,30
|
810 M | 1 |
| FY2029 |
€ 1,89
€ 1,83 – € 1,94
|
790 M | 1 |
| FY2028 |
€ 1,59
€ 0,71 – € 2,66
|
720 M | 5 |
Belangrijkste Punten
ROE of 2,30% is below average
Debt/Equity of 0,23 — conservative balance sheet
Generating 15,71M in free cash flow
P/E of 456,82 — premium valuation
Cash machine — converts 210,81% of earnings into free cash flow
Capital efficient — spends only 2,91% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)99,97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
2,30%
ROIC2,04%
Net Margin2,44%
Op. Margin5,25%
Veiligheid
Debt / Equity
0,23
Current Ratio11,69
Interest Coverage168,66
Waardering
P/E Ratio
456,82
P/B Ratio7,09
EV/EBITDA188,36
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 99,97% | Revenue Growth (3Y) | 106,24% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 305,11M | Net Income (TTM) | 7,45M |
| ROE | 2,30% | ROA | 1,18% |
| Gross Margin | 68,32% | Operating Margin | 5,25% |
| Net Margin | 2,44% | Free Cash Flow (TTM) | 15,71M |
| ROIC | 2,04% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,23 | Current Ratio | 11,69 |
| Interest Coverage | 168,66 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 456,82 | P/B Ratio | 7,09 |
| P/S Ratio | 11,16 | PEG Ratio | -4,71 |
| EV/EBITDA | 188,36 | Dividend Yield | 0,00% |
| Market Cap | 3,41B | Enterprise Value | 3,02B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 305,11M | 152,58M | 71,73M |
| Net Income | 7,45M | -41,57M | -82,68M |
| EPS (Diluted) | 0,06 | -0,93 | -1,85 |
| Gross Profit | 208,46M | 80,92M | 17,31M |
| Operating Income | 16,02M | -47,15M | -69,50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 632,65M | 302,06M | 191,68M |
| Total Liabilities | 152,55M | 134,31M | 161,20M |
| Shareholders' Equity | 480,11M | 167,75M | 30,47M |
| Total Debt | 108,90M | 109,38M | 146,35M |
| Cash & Equivalents | 495,98M | 191,48M | 97,27M |
| Current Assets | 560,56M | 227,82M | 115,50M |
| Current Liabilities | 47,96M | 28,39M | 66,80M |